CymaBay Therapeutics Inc. (CBAY)

NASDAQ: CBAY · IEX Real-Time Price · USD
2.77
-0.18 (-6.10%)
Jul 1, 2022 4:00 PM EDT - Market closed

Total Valuation

CBAY has a market cap or net worth of $234.56 million. The enterprise value is $125.22 million.

Market Cap 234.56M
Enterprise Value 125.22M

Important Dates

The next earnings date is Thursday, August 11, 2022, after market close.

Estimated Earnings Date Aug 11, 2022
Ex-Dividend Date n/a

Share Statistics

CBAY has 84.68 million shares outstanding. The number of shares has increased by 27.35% in one year.

Shares Outstanding 84.68M
Shares Change (YoY) +27.35%
Shares Change (QoQ) +13.64%
Owned by Insiders (%) 0.39%
Owned by Institutions (%) 79.38%
Float 62.12M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 2.18
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.68, with a Debt / Equity ratio of 0.74.

Current Ratio 13.68
Quick Ratio 13.43
Debt / Equity 0.74
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -92.30%, which is considered low. The company has a ROIC of -85.00%.

Return on Equity (ROE) -92.30%
Return on Assets (ROA) -62.40%
Return on Capital (ROIC) -85.00%
Revenue Per Employee n/a
Profits Per Employee -$1.70M
Employee Count 59
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -36.47% in the last 52 weeks. The beta is 1.08, so CBAY's price volatility has been similar to the market average.

Beta (1Y) 1.08
52-Week Price Change -36.47%
50-Day Moving Average 2.20
200-Day Moving Average 2.82
Average Volume (30 Days) 790,070

Short Selling Information

The latest short interest is 3.35 million, so 3.95% of the outstanding shares have been sold short.

Short Interest 3.35M
Short % of Shares Out 3.95%
Short % of Float 5.38%
Short Ratio (days to cover) 5.45

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -94.47M
Net Income -100.22M
EBITDA -93.58M
EBIT -94.27M
Earnings Per Share (EPS) -$1.32
Full Income Statement

Balance Sheet

The company has $188.56 million in cash and $79.22 million in debt, giving a net cash position of $109.34 million or $1.29 per share.

Cash & Cash Equivalents 188.56M
Total Debt 79.22M
Net Cash 109.34M
Net Cash Per Share $1.29
Book Value 107.38M
Book Value Per Share 1.27
Working Capital 178.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$74.23 million and capital expenditures $7,000, giving a free cash flow of -$74.23 million.

Operating Cash Flow -74.23M
Capital Expenditures 7,000
Free Cash Flow -74.23M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CBAY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -42.73%
FCF Yield -31.64%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -27.35%
Shareholder Yield -27.35%
Dividend Details

Analyst Forecast

The average price target for CBAY is $10.09, which is 264.26% higher than the current price. The consensus rating is "Buy".

Price Target $10.09
Price Target Difference 264.26%
Analyst Consensus Buy
Analyst Count 14
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a